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ABSTRACT 
Purpose The Trivandrum non-alcoholic fatty liver disease 
(NAFLD) cohort is a population-based study designed to 
examine the interaction between genetic and lifestyle 
factors and their association with increased risk of NAFLD 
within the Indian population.
Participants Between 2013 and 2016, a total of 2222 
participants were recruited to this cohort through 
multistage cluster sampling across the whole population 
of Trivandrum—a district within the state of Kerala, South 
India. Data were collected from all inhabitants of randomly 
selected households over the age of 25.
Findings to date Full baseline clinical and pathological 
data were collected from 2158 participants. This included 
detailed demographic profiles, anthropometric measures 
and lifestyle data (food frequency, physical activity and 
anxiety and depression questionnaires). Biochemical 
profile and ultrasound assessment of the liver were 
performed and whole blood aliquots were collected 
for DNA analysis. The NAFLD prevalence within this 
population was 49.8% which is significantly higher than 
the global pooled prevalence of 25%. This highlights 
the importance of robust, prospective studies like this 
to enable collection of longitudinal data on risk factors, 
disease progression and to facilitate future interventional 
studies.
Future plans The complete analysis of data collected 
from this cohort will give valuable insights into the 
interaction of the phenotypic and genotypic profiles that 
result in such a dramatic increased risk of NAFLD within 
the Indian population. The cohort will also form the basis of 
future lifestyle interventional studies, aimed at improving 
liver and metabolic health.
InTRoduCTIon
Rising levels of obesity, type 2 diabetes mellitus 
(T2DM) and the metabolic syndrome (MetS) 
are a global health concern. The risk of T2DM 
is increasing worldwide, particularly in Indian 
populations where the risk is higher in both 
native and migrant populations compared 
with other ethnicities,1 and at a lower body 
mass index (BMI).2 
One of the consequences of this metabolic 
pandemic is increasing prevalence of non-al-
coholic fatty liver disease (NAFLD) which is 
thought to be the hepatic manifestation of 
MetS. NAFLD encompasses a spectrum of 
disease from simple steatosis, non-alcoholic 
steatohepatitis, through increasing stages 
of fibrosis to cirrhosis—which may result in 
liver decompensation, hepatocellular carci-
noma and death. Individuals with NAFLD, 
particularly those with MetS, have higher 
overall mortality, cardiovascular mortality 
and liver-related mortality compared with the 
general population.3 NAFLD is particularly 
prevalent in Western populations,4 but with 
the westernisation of Asia-Pacific culture, we 
are seeing increasing levels of obesity, MetS 
and NAFLD in this group.5 The rise in MetS 
and its complications is variable according to 
region and degree of urbanisation—being 
induced by a variety of lifestyle factors such as 
diet and exercise habits.6
A recent meta-analysis showed that the 
pooled global prevalence of NAFLD is 25%.7 
The issue with this generalisation is that it is 
mainly based on large studies from the USA, 
which include small numbers of people of 
Indian ethnicity. The documented preva-
lence of NAFLD also varies depending on 
Strengths and limitations of this study
 ► This large population-based cohort is designed 
to examine the interaction between the genetic 
and lifestyle factors which contribute to increased 
non-alcoholic fatty liver disease risk in India.
 ► Though limited to the district of Trivandrum, popula-
tion-level sampling to include participants from both 
urban and rural domiciles makes it one of the largest 
cohort studies of its kind.
 ► Extensive baseline data include detailed cohort phe-
notyping (including food frequency and physical ac-
tivity data) as well as biochemical profiles and whole 
blood aliquots for DNA analysis.
 ► Low rates of migration and robust cohort infrastruc-
ture will enable comprehensive longitudinal fol-
low-up and form the basis for future interventional 
studies.
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the diagnostic tool used. In low/middle-income coun-
tries (like India) it is difficult to perform large popula-
tion-based studies, with those that are published being 
biased towards urban, tertiary centres where ultrasound 
and biopsy are more readily available.8 Evidence has 
shown that within these urban areas—often of higher 
socioeconomic class—there are higher rates of NAFLD 
and as such these studies are likely to give an overestimate 
of NAFLD prevalence in India.9
The creation of the Trivandrum NAFLD cohort was 
funded and supported by the NIHR Nottingham Diges-
tive Diseases Biomedical Research Unit, Nottingham 
University Hospitals NHS Trust and the University Of 
Nottingham, Nottingham, UK, with data collection and 
management run through the Population Health and 
Research Institute (PHRI), Trivandrum, Kerala, India. 
PHRI has specific expertise in population-based studies, 
having established and run the Trivandrum Tobacco 
Study (a study of tobacco habits of 0.4 million men in 
Trivandrum), which has undergone five yearly follow-ups 
since 2002 (data can be found through https://www. 
ctsu. ox. ac. uk/ research/ the- trivandrum- tobacco- study). 
The Trivandrum NAFLD cohort was created to examine 
how the interaction between genetics and lifestyle factors 
results in increased risk of NAFLD within this population. 
The cohort will combat the paucity of population-based 
studies in India and enable accurate estimation of 
NAFLD prevalence within an Indian population as a 
whole (including both urban and rural domiciles). It will 
also allow the development of a nested case–control study 
to look at the impact of different variables on NAFLD 
risk. Through large, population-based sampling of a 
relatively static populace, this cohort will also facilitate 
further disease-specific studies (including interventional 
studies), genetic studies, and has the capability of gener-
ating longitudinal follow-up data.
CohoRT deSCRIPTIon
Cohort creation
Trivandrum (Thiruvananthapuram) is the southern-
most district in the state of Kerala, located on the south-
western coast of India (figure 1). At the time of the Indian 
census in 2011, it had a population of 3.3 million divided 
into urban and rural domiciles (urban 54%, rural 46%—
census data captured through https://www. census2011. 
co. in/). The Trivandrum NAFLD cohort was created 
between February 2013 and July 2016 through popula-
tion-based sampling of all inhabitants over the age of 25 
years.
As described, Trivandrum has both urban and rural 
districts. As per the population census, the rural districts 
are divided into 12 blocks, which are themselves formed 
of 78 panchayats (originally denoting a village council). 
Panchayats are then subdivided further into wards (orig-
inally denoting a local authority area—usually indicating 
a neighbourhood). The urban districts are divided into 
wards only.
The enrolment of study participants was done through 
unweighted multistage cluster sampling. Using random 
number tables, 3 of 12 rural blocks were selected (made 
up of 22 panchayats), 4 rural panchayats were selected 
out of 22 (made up of 71 wards) and, finally, 40 of 71 
wards were selected. Using the same technique, 7 of 81 
urban wards were selected (figure 2).
Using the Trivandrum electoral roll from 2011, house-
holds within these wards were grouped into clusters of 
seven. Using random number table, 112 of 2420 rural 
clusters and 128 of 2631 urban clusters were identified 
for sampling. Each household within the chosen clus-
ters was sampled, and through house-to-house survey by 
local social workers all eligible inhabitants were invited to 
enrol. For some households this meant repeated visits to 
ensure all those who were eligible (anyone over the age 
of 25 years) were given the opportunity to participate. At 
the time of recruitment, within the household, baseline 
demographic, anthropometric and medical history data 
were collected.
Originally the aim was to recruit around 2000 cases 
of NAFLD. Based on an estimated NAFLD prevalence 
of 31.8% from a previous pilot study,10 this would mean 
recruiting a total cohort of 10 000 participants. Unfor-
tunately, due to time constraints, cohort recruitment at 
household level was ceased at around 2000 participants 
(figure 3), which based on estimated prevalence would 
result in 840 NAFLD cases.
In order to collect pathological data (including bloods 
and abdominal ultrasound), study camps were held 
within the area local to the selected wards and those who 
had been recruited were invited to attend. Of the orig-
inal 2222 population sample, 2161 participants attended 
the camps—demonstrating a high attendance rate with 
only 3% dropout. Three participants did not have an 
ultrasound so were excluded, leaving the total number 
of participants as 2158. Analysis of the demographic/
anthropometric data of those who did and did not have an 
ultrasound shows that a higher proportion of men (61% 
vs 40.6%, p<0.001) and a higher proportion of people 
within the rural setting (73.4% vs 46.3%, p<0.001) did not 
attend. This is likely due to the difficulty in getting to the 
rural camps (which covered a larger geographical area 
than the urban camps), and that men were often limited 
by their need to work.
data collection
Clinical data were collected through house-to-house 
survey and pathological data were collected through the 
local study camps. This is outlined below.
Clinical data
Potential participants were approached and consented 
to the cohort through house-to-house survey by social 
workers within their wards. Initial clinical data were 
collected at the time of consent within the partici-
pant’s home. Baseline demographic data included 
date of birth, gender, level of education, work status, 
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Figure 1 Map of Kerala.
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marital status and religion. Information on medical 
history was also documented along with history 
of tobacco smoking/chewing and alcohol intake. 
Anthropometric data collected during household 
visits included height measured in centimetres using 
a wall-mounted vertical rule, weight measured in kilo-
grams using mechanical standing scales, waist circum-
ference—taking an average of two measurements in 
centimetres using a non-expandable tape between the 
lower rib margin and iliac crest, and an average of 
three blood pressure readings in mm Hg taken using 
a manual cuff in a sitting position. Participants under-
took a regional Food Frequency Questionnaire (FFQ), 
designed to incorporate variation in nutrient intake 
attributed to local recipes according to domicile, 
social class and religion. The validation of this FFQ 
is ongoing—using repeated 24 hours’ food diaries 
and blood/urine biomarkers. Participants also under-
took the Global Physical Activity Questionnaire11 and 
Duke Anxiety-Depression Scale (Hospital Anxiety and 
Depression Scale).12
Pathological data
Participants who attended the study camps had blood 
taken for assessment of liver function, platelet count, 
fasting glucose, insulin and lipids. Additional whole blood 
aliquots were taken for DNA extraction. Participants then 
underwent abdominal ultrasonography to assess pres-
ence and grade of fatty infiltration (Grade 1: liver echo-
genicity is increased. Grade 2: echogenic liver obscures 
the echogenic walls of portal vein braches. Grade 3: echo-
genic liver obscures the diaphragmatic outline).13 Those 
who had evidence of NAFLD subsequently underwent 
transient elastography (FibroScan) as a surrogate marker 
to stage degree of fibrosis (≥8 kPa indicating presence of 
significant fibrosis).
Statistical analyses
Categorical data are presented as numbers 
(percentage) and continuous data as mean (SD) for 
normally distributed data and medians (range) for 
non-parametric data. Univariate analysis to compare 
characteristics of the cohort with/without NAFLD 
was undertaken using Student’s t-test (normal contin-
uous), Mann-Whitney U test (non-normal contin-
uous) and Χ2 test (categorical).
Figure 2 Trivandrum non-alcoholic fatty liver disease 
(NAFLD) cohort sampling framework.
Figure 3 Trivandrum non-alcoholic fatty liver disease (NAFLD) cohort recruitment diagram.
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Baseline characteristics
Demographic data from the population sample (n=2222) 
and NAFLD cohort (n=2158) compared with the census 
data of Trivandrum in 2011 are outlined in table 1. The 
NAFLD cohort has a larger proportion of women to men 
and a larger proportion of Hindu population than the 
national average. Importantly, the proportion of rural 
and urban population within the cohort matches the 
census, implying adequate population-level sampling.
FIndIngS To dATe
A total of 2158 participants were included in the final 
cohort. The prevalence of NAFLD within this popula-
tion-based cohort is 49.8% (n=1075).
Within this cohort, a nested NAFLD case–control study 
has been done to look at the difference in aetiological 
factors between those with NAFLD and those without. In 
order to do this, data from the original NAFLD cohort 
(2158) were cleaned to remove other causes of non-NA-
FLD-related liver disease such as alcohol intake >21 units 
per week and alternate causes of an echo-bright liver 
(such as history of viral hepatitis or other liver disease), 
leaving a subcohort of 2089 (NAFLD 49.8%). Baseline 
demographic data from this subcohort are presented in 
table 2.
Overall, females outnumbered males and consti-
tuted 1277 of the total 2089 participants. 55.2% of the 
urban population had NAFLD compared with 43.4% of 
the rural population (an unadjusted OR of 1.60, 1.35–
1.91)—a finding which is consistent with the literature 
on increased NAFLD prevalence in areas of higher socio-
economic class.14 As expected, mean BMI was higher in 
the NAFLD group (OR 1.79 if overweight, OR 3.25 if 
obese) as was rate of diabetes (OR 2.27, 1.85–2.79) and 
MetS (OR 2.26, 1.86–2.74). These data are presented in 
table 3. Under logistic regression, for every unit increase 
in BMI, the odds of having NAFLD increases by 1.17 
(17%) (1.15–1.20, p<0.001).
These data confirm commonality of NAFLD risk factors 
between India and the Western world. Increasing levels 
of obesity and the dramatic rise in diabetes prevalence in 
India1 is reflected in the WHO Global Burden of Disease 
study, which shows that hypertension and raised fasting 
blood glucose are the leading cause of non-communi-
cable disease in India, unlike other low/middle-income 
countries where childhood malnutrition and unsafe water 
predominate.15 This is reflected within this cohort, where 
we demonstrate high rates of diabetes—well above the 
2011 estimated population prevalence of 8.3%1—even 
within the control group. The main reason for this is the 
fact that the inception cohort from which the case and 
control groups were identified included only people of 25 
years of age and older, enriching the cohort with people 
with an age group where prevalence of type 2 diabetes is 
expected to be substantially higher. In addition, collection 
of fasting blood glucose levels at enrolment enabled us to 
identify those who meet the International Diabetes Feder-
ation criteria for diabetes without previous diagnosis.
Interestingly, presence of obesity conveys the strongest 
risk of NAFLD within this group (above diabetes) which 
highlights the ‘Asian paradox’—where cardiovascular risk 
increases with BMI in Asians, as in other ethnicities, but at 
a lower BMI. These data support the significant impact of 
BMI on risk of disease in this group and the reclassifica-
tion of BMI cut-offs that was implemented in 2000.2
Recruitment to the Trivandrum NAFLD cohort was 
completed in July 2016. As yet, it has not undergone a 
complete follow-up. The aim of the project is to collect 
Table 1 Comparison of the population sample demographics to the Trivandrum population census and comparison of the 
NAFLD cohort demographics to the population sample
Demography
Census
(n=3 301 427)
Population sample
(n=2222) p value
NAFLD cohort
(n=2158) p value
Gender
  Male, n (%) 1 581 678 (47.9) 915 (41.2) * 876 (40.6) *
  Female, n (%) 1 719 749 (52.1) 1307 (58.8) 1282 (59.4)
Domicile
  Rural, n (%) 1 529 831 (46.3) 1046 (47.1) p=0.49 999 (46.3) p=1.04
  Urban, n (%) 1 771 596 (53.7) 1176 (52.9) 1159 (53.7)
  Literacy (%) 93.0 98.0 p=0.09 98.0 p=0.09
Religion
  Hindu, n (%) 2 194 057 (66.5) 1821 (81.9) * 1765 (81.8) *
  Muslim, n (%) 452915 (13.7) 170 (7.7) * 167 (7.7) *
  Christian, n (%) 630573 (19.1) 231 (10.4) * 226 (10.5) *
  Other, n (%) 23882 (1) 0 0
*p<0.001.
NAFLD, non-alcoholic fatty liver disease. 
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longitudinal data on risk factors for NAFLD progression 
and to make an assessment of long-term outcomes such 
as incident diabetes, cardiovascular events and all-cause 
mortality rates using verbal autopsy—a validated instru-
ment used to ascertain time and cause of death.16 Further 
lifestyle data that were collected from the cohort were 
under review with the aim to look at the impact of diet and 
physical activity on risk of NAFLD, both in native Indians 
and on those who now live in the UK. Data on liver stiff-
ness within the NAFLD subgroup will be combined with 
a larger piece of work looking at the identification and 
stratification of liver disease in Trivandrum as a whole.
The cohort also forms the basis of a Global Challenges 
Research Fund (GCRF) recently awarded to the NIHR 
Table 2 Nested NAFLD case–control demographics. Diabetes defined as formal diagnosis, treatment or fasting glucose 
>126 mg/dL
Demography NAFLD n=1040 Control n=1049 p value
Age, mean (SD) 48.34 (10.74) 45.98 (12.31) *
Gender
  Male, n (%) 473 (45.5) 339 (32.3) * 
  Female, n (%) 567 (54.5) 710 (67.7)
Domicile
  Rural, n (%) 417 (40.1) 543 (51.8) * 
  Urban, n (%) 623 (59.9) 506 (48.2)
Literacy, n (%) 1018 (97.9) 1027 (97.9) 0.978
BMI, mean (SD) 26.90 (4.16) 24.30 (4.08) *
Underweight, n (%) <18.5 kg/m2 4 (0.4) 68 (6.5)
Normal weight, n (%) 18.5–22.9 kg/m2 165 (15.9) 336 (32)
Overweight, n (%) 23–24.9 kg/m2 195 (18.8) 222 (21.2)
  Obese, n (%) >25 kg/m2 675 (64.9) 423 (40.3)
Diabetes, n (%) 355 (34.13) 195 (18.59) * 
  HOMA-IR, median (IQR) 0.13 (0.13) 0.07 (0.07) * 
Metabolic syndrome, n (%) 417 (40.1) 240 (22.88) *
  Cholesterol, mean (SD) 219.19 (44.05) 212.26 (44.34) * 
  HDL, mean (SD) 47.65 (11.25) 50.35 (11.83) * 
  Triglycerides, median (IQR) 133 (85) 94.5 (59) * 
  LDL-C, mean (SD) 140.71 (39.04) 140.03 (38.87) 0.689 
HOMA-IR ((fasting insulin*fasting glucose)/405) calculated for those not on treatment for diabetes. LDL-C=(total cholesterol−
HDL cholesterol−(triglycerides/5)). 
*p<0.001.
BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin 
resistance, LDL-C, low-density lipoprotein cholesterol; NAFLD, non-alcoholic fatty liver disease. 
Table 3 NAFLD ORs adjusting for sex, domicile, BMI category (with normal weight as baseline), diabetes and metabolic 
syndrome. Variables were mutually adjusted for each other with baseline categories being those variables presented
Variable Unadjusted OR (95% CI, p value) Adjusted OR (95% CI, p value)
Male sex 1.75 (1.46 to 2.09, p<0.001) 2.22 (1.82 to 2.72, p<0.001)
Urban domicile 1.60 (1.35 to 1.91, p<0.001) 1.21 (1.00 to 1.46, p=0.048)
BMI
  Underweight <18.5 kg/m2 0.12 (0.04 to 0.34, p<0.001) 0.14 (0.05 to 0.41, p<0.001)
  Overweight 23–24.9 kg/m2 1.79 (1.36 to 2.34, p<0.001) 1.78 (1.34 to 2.35, p<0.001)
  Obese >25 kg/m2 3.25 (2.58 to 4.10, p<0.001) 3.27 (2.57 to 4.16, p<0.001)
Diabetes 2.27 (1.85 to 2.79, p<0.001) 1.63 (1.28 to 2.07, p<0.001)
Metabolic syndrome 2.26 (1.86 to 2.74, p<0.001) 1.62 (1.29 to 2.07, p<0.001)
BMI, body mass index; NAFLD, non-alcoholic fatty liver disease.
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Nottingham Biomedical Research Centre (BRC) in 
collaboration with PHRI to develop lifestyle interventions 
for improved liver and metabolic health in South India. 
As a part of GCRF, a pilot randomised controlled trial 
of 16 months’ dietary intervention with low glycaemic 
index food with yoga sessions versus yoga sessions alone 
has been initiated in the NAFLD cohort developed and 
described here ( ClinicalTrials. gov NCT03844165).
Finally, DNA has been extracted from whole blood 
aliquots from this cohort with the aim to complete the 
first genome-wide association study of NAFLD within an 
Indian population.
STRengThS And lImITATIonS
The biggest strength of the Trivandrum NAFLD cohort 
is the fact that it was designed to collect detailed anthro-
pometric, clinical and pathological data at a population 
level, representing the full spectrum of demography of 
a large Indian state. Through population-level sampling 
we have enabled accurate estimation of NALFD preva-
lence, which given its significant departure from the esti-
mated global prevalence has filled an important gap in 
the knowledge base. NAFLD prevalence of 31.8% was esti-
mated from a previous pilot study,10 which was reliant on 
raised liver enzymes to identify patients for further inves-
tigations, hence, underestimated the true prevalence in 
this population. Through the utilisation of local social 
workers within the community, PHRI has created a cohort 
with excellent uptake and retention of participants, has 
methods in place to document rates of migration and 
accurate mortality data as well as having the infrastruc-
ture and manpower in place to facilitate longitudinal and 
interventional studies.
The main limitation of the study from a clinical 
perspective is the use of ultrasound as the diagnostic tool 
for NAFLD. Ultrasound has been shown to have a poor 
yield in the diagnosis of microvesicular fat within the 
liver, with an overall sensitivity of 43% and specificity of 
73%.17 This means that our NAFLD prevalence of 49.8% 
may in fact be an underestimate. Liver biopsy is generally 
considered to be the gold standard for NAFLD diagnosis, 
but its invasive nature combined with its inherent risk of 
sampling error makes it unsuitable for population-based 
studies. Despite this, the message that NAFLD prevalence 
is significantly higher in this Indian population compared 
with the global estimates is an important one. Finally, 
although representative of a large Indian population, the 
data collected from this cohort are not necessarily repre-
sentative of the India as a whole—whose diverse popula-
tion includes thousands of distinct and unique cultures.
PATIenT InvolvemenT
 Participants of the Trivandrum NFALD cohort were not 
involved in setting the research question or the outcome 
measures of this project, but during data collection the 
patient and public involvement team from the NIHR 
Nottingham BRC ran a 3-day workshop alongside PHRI 
in Trivandrum. During this workshop, participants were 
consulted on their opinions of having lifestyle informa-
tion collected, and the best way to do this. This qualita-
tive feedback has helped shape the way we approach data 
collection from a cultural standpoint in this ethnic group.
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